# Avis Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avis-co

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.aivis.kr
- Total disclosed funding: $0.5M
- Latest round: Seed (Nov 14, 2023)
- Investors on record: 2

## About

Founded in 2021 and based in Seoul, South Korea, Avis Co., Ltd., also known as AIVIS Incorporated, operates as a medical technology company that develops AI-enabled breast cancer diagnostic assistance solutions. As of 2023, the company is led by its CEO, Daehong Lee. In November 2023, AIVIS raised KRW 700 million in seed funding from the Holistic Growth Initiative, Korea Tech Incubator for Startup, being selected for the Accelerator Investment-Driven Tech Incubator Program.

The firm’s product line includes AIVIS-WORKBOX, which is an AI-enabled automated annotation platform; AIVIS-PATHOWAY, an AI-enabled clinical research platform that develops biomarkers and drugs for cancer treatment; AIVIS-BREAS, an AI-enabled diagnostic platform that helps pathologists predict breast cancer treatment and prognosis; a MedTech-based software platform, which is a no-code auto-labeling platform for brain tumor histopathology images; AIVIS-EYE, a AI-driven platform that guides eye surgeons in selecting the most appropriate refractive surgery type by predicting the likelihood of myopic regression; and many more.

## Funding rounds

- Seed, Nov 14, 2023, $0.5M — Holistic Growth Initiative, Korea Tech Incubator for Startup
- Seed, Sep 1, 2023 — Holistic Growth Initiative

## Investors

- Holistic Growth Initiative (https://capitalatlas.ai/funds/holistic-growth-initiative) — Seed
- Korea Tech Incubator for Startup — Seed